211 related articles for article (PubMed ID: 7535328)
21. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
[TBL] [Abstract][Full Text] [Related]
22. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
23. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
Cariati E; Brizzi L; Periti E
J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
[TBL] [Abstract][Full Text] [Related]
24. The impact of MSAFP screening on genetic services, 1984-1986.
Greenberg F
Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
[TBL] [Abstract][Full Text] [Related]
25. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
26. Current techniques of prenatal screening for Down syndrome.
Cardwell MS; Gay JW
Mo Med; 1990 May; 87(5):295-7. PubMed ID: 1694954
[TBL] [Abstract][Full Text] [Related]
27. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
Kaffe S; Hsu LY
Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
[TBL] [Abstract][Full Text] [Related]
28. Down syndrome and low maternal serum alpha fetoprotein.
Jacobs S; Giles W
Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):335-40. PubMed ID: 1707270
[TBL] [Abstract][Full Text] [Related]
29. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
30. Local norms of maternal serum alpha-fetoprotein values in early second trimester: a prelude to a Down's syndrome screening programme incorporating maternal serum alpha-fetoprotein values.
Lai FM; Yeo SH; Yo SL; Tan IK
Singapore Med J; 1991 Apr; 32(2):134-7. PubMed ID: 1710394
[TBL] [Abstract][Full Text] [Related]
31. Down syndrome maternal serum marker screening after 18 weeks' gestation.
Muller F; Dreux S; Oury JF; Luton D; Uzan S; Uzan M; Levardon M; Dommergues M
Prenat Diagn; 2002 Nov; 22(11):1001-4. PubMed ID: 12424764
[TBL] [Abstract][Full Text] [Related]
32. Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome.
Drugan A; Dvorin E; Koppitch FC; Greb A; Krivchenia EL; Evans MI
Obstet Gynecol; 1989 Feb; 73(2):271-4. PubMed ID: 2463504
[TBL] [Abstract][Full Text] [Related]
33. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
Wenstrom KD; Boots LR; Cosper PC
J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763
[TBL] [Abstract][Full Text] [Related]
34. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
Heyl PS; Miller W; Canick JA
Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
[TBL] [Abstract][Full Text] [Related]
35. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
36. Are Down syndrome fetuses detected through maternal serum screening similar to those remaining undetected?
Christiaens GC; Hagenaars AM; Akkerman C; De France HF
Prenat Diagn; 1996 May; 16(5):437-42. PubMed ID: 8844002
[TBL] [Abstract][Full Text] [Related]
37. Adverse pregnancy outcome after a false-positive screen for Down syndrome using multiple markers.
Pergament E; Stein AK; Fiddler M; Cho NH; Kupferminc MJ
Obstet Gynecol; 1995 Aug; 86(2):255-8. PubMed ID: 7542379
[TBL] [Abstract][Full Text] [Related]
38. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
Hayashi M; Kohzu H
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
[TBL] [Abstract][Full Text] [Related]
39. First-trimester alpha-fetoprotein screening for Down syndrome.
Fuhrmann W; Altland K; Jovanovic V; Holzgreve W; Miny P; Wenger D; Rauskolb R
Prenat Diagn; 1993 Mar; 13(3):215-8. PubMed ID: 7685089
[TBL] [Abstract][Full Text] [Related]
40. Biochemical screening tests for Down syndrome.
Coetzee E; Viljoen D
S Afr Med J; 1995 Feb; 85(2):72-3. PubMed ID: 7541163
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
